Cellular and ionic mechanisms underling erythromycin-induced long QT intervals and Torsade de Pointes

Journal of the American College of Cardiology

Volumn 28, Issue 7, 1997, Pages 1836-1848

  Antzelevitch, Charles ^a   Sun, Zhuo Qian ^a   Zhang, Zi Qing ^a   Yan, Gan Xin ^a  

^a MASONIC MEDICAL RESEARCH LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPOLARIZATION; DOG; ELECTROCARDIOGRAM; HEART MUSCLE CELL; ION CURRENT; LONG QT SYNDROME; MALE; NONHUMAN; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; TORSADE DES POINTES;

ACTION POTENTIALS; ANIMALS; ANTI-BACTERIAL AGENTS; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGY; ENDOCARDIUM; ERYTHROMYCIN; HEART; HEART VENTRICLES; LONG QT SYNDROME; MALE; MICROELECTRODES; MYOCARDIUM; PATCH-CLAMP TECHNIQUES; PERICARDIUM; POTASSIUM CHANNELS; TORSADES DE POINTES;

EID: 0030468097     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00377-4     Document Type: Article

References (53)

1. 1. Jackman WM, Friday KJ, Andersen JL, Aliot EM, Clark MA, Lazzara R. The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis 1988;2:115-72.
2. 2. Moss AJ, Robinson JL. Long QT syndrome. Heart Dis Stroke 1992;1:309-14.
3. 3. Schwartz PJ, Moss AJ, Vincent GM, Crampton RS. Diagnostic criteria for the long QT syndrome: an update. Circulation 1993;88:782-4.
4. 4. El-Sherif N. Early afterdepolarizations and arrhythmogenesis: experimental and clinical aspects. Arch Mal Coeur 1991;84:227-34.
5. 5. Antzelevitch C, Sicouri S. Clinical relevance of cardiac arrhythmias generated by afterdepolarizations: the role of M cells in the generation of U waves, triggered activity and torsade de pointes. J Am Coll Cardiol 1994;23:259-77.
6. 6. McComb JM, Campbell NPS, Cleland JGF. Recurrent ventricular tachycardia associated with QT prolongation after mitral valve replacement and its association with intravenous administration of erythromycin. Am J Cardiol 1984;54:922-3.
7. 7. Guelon D, Bedock B, Chartier C, Haberer JP. QT prolongation and recurrent "torsades de pointes" during erythromycin lactobionate infusion [abstract]. Am J Cardiol 1986;58:666.
8. 8. Freedrnan RA, Anderson KP, Green LS, Mason JW. Effect of erythromycin on ventricular arrhythmias and ventricular repolarization in idiopathic long QT syndrome. Am J Cardiol 1987;59:168-9.
9. 9. Nattel S, Talajic M, Lemery R, Roy D. Erythromycin induced long QT syndrome: concordance with quinidine and underlying cellular electrophysiologic mechanism. Am J Med 1990;89:235-8.
10. 10. Rubart M, Pressler ML, Pride HP, Zipes DP. Electrophysiological mechanisms in a canine model of erythromycin-associated long QT syndrome. Circulation 1993;88:1832-44.
11. 11. Farrar HC, Walsh-Sukys MC, Kyllonen K, Blumer JL. Cardiac toxicity associated with intravenous erythromycin lactobionate: two case reports and a review of the literature. Pediatr Infect Dis J 1993;12:688-91.
12. 12. Daleau P, Lessard E, Groleau M, Turgeon J. Erythromycin blocks the rapid component of the delayed rectifier potassium current and lengthens repolarization of guinea pig ventricular myocytes. Circulation 1995;91:3010-6.
13. 13. Sicouri S, Antzelevitch C. Afterdepolarizations and triggered activity develop in a select population of cells (M cells) in canine ventricular myocardium: the effects of acetylstrophantidin and Bay K 8644. PACE 1991;14: 1714-20.
14. 14. Sicouri S, Antzelevitch C. Drug-induced afterdepolarizations and triggered activity occur in a discrete subpopulation of ventricular muscle cell (M cells) in the canine heart: quinidine and digitalis. J Cardiovasc Electrophysiol 1993;4:48-58.
15. 15. Antzelevitch C, Sicouri S, Lukas A, Nesterenko VV, Liu DW, Di Diego JM. Regional differences in the electrophysiology of ventricular cells: physiological and clinical implications. In: Zipes DP, Jalife J, editors. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia: WB Saunders, 1994:228-45.
16. 16. Zhang ZQ, Antzelevitch C. Erythromycin produces prominent action potential prolongation and early afterdepolarization (EAD)-induced triggered activity in M but not epicardial or endocardial regions of the canine ventricle [abstract]. Circulation 1993;88 Suppl I:I-327.
17. 17. Fishbein MC, et al. Early phase acute myocardial infarct size quantification: validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J 1995;101:593-600.
18. 18. Chilian WM, Eastham CL, Marcus ML. Microvascular distribution of coronary vascular resistance in beating left ventricle. Am J Physiol 1986;251: H779-88.
19. Ks contributes to the longer action potential of the M cell. Circ Res 1995;76:351-65.
20. + currents. Pflugers Arch 1992;420:180-6.
21. + current: differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol 1990;96:195-215.
22. + in single cardiac Purkinje cells. Am J Physiol 1989;257:C1086-92.
23. + current is composed of two currents in guinea pig atrial cells. Am J Physiol 1991;260: H393-9.
24. 24. Liu DW, Gintant GA, Antzelevitch C. Ionic bases for electrophysiological distinctions among epicardial, midmyocardial, and endocardial myocytes from the free wall of the canine left ventricle. Circ Res 1993;72:671-87.
25. 25. Sigworth FJ. Electronic design of the patch clamp. In: Sakmann B, Neher E, editors. Single-Channel Recording. New York: Plenum, 1983:3-35.
26. 26. Noble D, Tsien RW. Outward membrane currents activated in the plateau range of potentials in cardiac Purkinje fibers. J Physiol (Lond) 1969;200: 205-31.
27. 27. Sanguinetti MC, Jurkiewicz NK, Scott AL, Siegl PKS. Isoproterenol antagonizes prolongation of refractory period by the class III antiarrhythmic agent E-4031 in guinea pig myocytes. Circ Res 1991;68:77-84.
28. Kr: implications for torsade de pointes and reverse use-dependence. Circulation 1996;93:407-11.
29. +-induced early afterdepolarizations in Purkinje fibers. J Cardiovasc Electrophysiol 1994;5:933-44.
30. 30. Attwell D, Cohen IS, Eisner DA, Ohba M, Ojeda C. The steady-state tetrodotoxin-sensitive ("window") sodium current in cardiac Purkinje fibers. Pflugers Arch 1979;379:137-42.
31. 31. Gintant GA, Daytner NB, Cohen IS. Slow inactivation of a tetrodotoxinsensitive current in canine cardiac Purkinje fibers. Biophys J 1984;45:509-12.
32. 32. Carmeliet E. Slow inactivation of the sodium current in rabbit cardiac Purkinje fibers. Pflugers Arch 1987;408:18-26.
33. 33. Kiyosue T, Arita M. Late sodium current and its contribution to action potential configuration in guinea pig ventricular myocytes. Circ Res 1989; 64:389-97.
34. 34. Vos MA, Verduyn SC, Gorgels APM, Lipcsei GC, Wellens HJ. Reproducible induction of early afterdepolarizations and torsade de pointes arrhythmias by d-sotalol and pacing in dogs with chronic atrioventricular block. Circulation 1995;91:864-72.
35. 35. Verduyn SC, Vos MA, Gorgels APM, van der Zande J, Leunissen JDM, Wellens HJ. The effect of flunarizine and ryanodine on acquired torsades de pointes arrhythmias in the intact canine heart. J Cardiovasc Electrophysiol 1995;6:189-200.
36. 36. Coumel P. Early afterdepolarizations and triggered activity in clinical arrhythmias. In: Rosen MR, Janse MJ, Wit AL, editors. Cardiac Electrophysiology: A Text Book. Mount Kisco (NY): Futura, 1990:387-411.
37. 37. Moss AJ. Long QT syndrome. In: Podrid PJ, Kowey PR, editors. Cardiac Arrhythmia: Mechanisms, Diagnosis and Management. Baltimore: Williams & Wilkins, 1995:1110-20.
38. 38. Locati EH, Maison-Blanche P, Dejode P, Cauchemez B, Coumel P. Spontaneous sequences of onset of torsade de pointes in patients with acquired prolonged repolarization: quantitative analysis of Holter recordings. J Am Coll Cardiol 1995;25:1564-75.
39. 39. Cobbe SM, Hoffman E, Ritzenhoff A, Brachmann J, Kubler W, Senges J. Action of sotalol on potential reentrant pathways and ventricular tachyarrhythmias in conscious dogs in the late postmyocardial infarction phase. Circulation 1983;68:865-71.
40. 40. Habbab MA, El-Sherif N. TU alternans, long QTU, and torsade de pointes: clinical and experimental observations. PACE 1992;15:916-31.
41. 41. Sasyniuk BI, Brunet S. Torsade de pointes induced by quinidine. d-sotalol, and E-4031 in the isolated rabbit heart: importance of interval dependent dispersion of repolarization [abstract]. PACE 1995;18 Suppl:II-904.
42. 42. Keren A, Tzivoni D, Gavish D, et al. Etiology, warning signs and therapy of torsades de pointes. Circulation 1981;64:1167-74.
43. 43. Guelon D, Bedock B, Chartier C, Haberer JP. QT prolongation and recurrent "torsade de pointes" during lactobionate erythromycin infusion. Am J Cardiol 1986;58:666.
44. 44. Schoenenberger RA, Haefeli WE, Weiss P, Ritz RF, Association of intravenous erythromycin and potentially fatal ventricular tachycardia with QT prolongation (torsades de pointes). BMJ 1990;300:1375-6.
45. 45. Freedman RA, Anderson KP, Green LS, Mason JW. Effect of erythromycin on ventricular arrhythmias and ventricular repolarization in idiopathic long QT syndrome. Am J Cardiol 1987;59:168-9.
46. 46. Austin KL, Mather LE, Philpot CR, McDonald PJ. Intersubject and dose-related variability after intravenous administration of erythromycin. Br J Clin Pharmacol 1980;10:273-9.
47. 47. Nightingale SL. New antiarrhythmic approved. JAMA 1992;268:3418.
48. 48. Brandriss MW, Richardson WS, Barold SS. Erythromycin-induced QT prolongation and polymorphic ventricular tachycardia (torsade de pointes): case report and review. Clin Infect Dis 1994;18:995-8.
49. 49. Barold SS. Torsade de pointes induced by erythromycin. Intelligence Reports in Cardiac Pacing and Electrophysiology 1994;13:5.
50. 50. Woosley RL, Chen YW, Freiman JP, Gillis RA. Mechanism of the cardiotoxic actions of terfenadine. JAMA 1993;269:1532-6.
51. 51. Honig PK, Woosley RL, Zamani K, Conner DP, Cantilena LR. Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin. Clin Pharmacol Ther 1992;52:231-8.
52. 52. Echizen H, Kawasaki H, Chiba K, Tani M, Ishizaki T. A potent inhibitory effect of erythromycin and other macrolide antibiotics on the mono-N-dealkylation metabolism of disopyramide with human liver microsomes. J Pharmacol Exp Ther 1993;264:1425-31.
53. 53. Roden DM. The study of pharmacokinetics and pharmacodynamics as a tool for understanding mechanisms of antiarrhythmic drug action. In: Breithardt G, Borggrefe M, Camm J, Shenasa M, editors. Antiarrhythmic Drugs: Mechanisms of Antiarrhythmic and Proarrhythmic Actions. Berlin: Springer-Verlag, 1995:290-9.